Prevalence of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Following Defect Correction: A Systematic Review and Meta-analysis

Importance Understanding the disease burden of repaired pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is essential for guiding healthcare strategies, yet data are lacking in this area. Objective To estimate the prevalence of pulmonary arterial hypertension (PAH) following defect correction in patients with congenital heart disease (CHD). Data sources A systematic review and meta-analysis was performed using PubMed, Embase and Cochrane databases. Study selection Longitudinal cohort published between 1970-2023 involving CHD patients who underwent defect correction and were subsequently diagnosed with PAH were reviewed. Eligible studies reporting the prevalence of repaired PAH-CHD at least 3 months post-repair was included. Study selection was conducted independently by two reviewers. The primary outcome was the prevalence of PAH in patients following CHD defect correction. Results Across 58 studies (7,036 participants), the random-effects pooled prevalence of reported post-repair PAH/PH was 10.8% (95% CI 7.3-15.0, I2 = 95.6%; prediction interval 0-50.1%). Prevalence was 9.0% (95% CI 3.3-17) in studies using right heart catheterisation, 19.3% (CI 10.6-29.7) in studies using echocardiography and 16.1% (CI 8.6- 25.1%) in studies using both modalities (p=0.19). Prevalence was highest in the adult-only cohort (18.5%, 95%CI 11.8-26.2) and lower in paediatric only (7.6%, 95%CI 3-13.5) and mixed-age cohorts (7.5%,95%CI1.7-16.3), p=0.039. Preoperative pulmonary hypertension (PH) was the strongest predictor of post-repair PAH and remained predictive on adjusted meta-regression (p<0.01). Conclusion and relevance PAH following defect repair remains a significant clinical dilemma requiring standardised diagnostic criteria and robust risk stratification tools to guide management.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Quality of Care and Clinical Outcomes
Published
2026-11-19
DOI
https://doi.org/10.1093/ehjqcco/qcag153
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prevalence of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Following Defect Correction: A Systematic Review and Meta-analysis

Konstantinos Dimopoulos, Katrijn Jansen, Shahin Moledina, Kaushiga Krishnathasan et al.
2 links
European Heart Journal - Quality of Care and Clinical Outcomes
Pulmonary Hypertension Research and Treatments
article

Prevalence of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease Following Defect Correction: A Systematic Review and Meta-analysis

Konstantinos Dimopoulos, Katrijn Jansen, Shahin Moledina, Kaushiga Krishnathasan, Sadia Quyam, Robin Condliffe, Andrew Constantine, Paul Clift, Stephen J Wort
article en

Abstract

Importance Understanding the disease burden of repaired pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is essential for guiding healthcare strategies, yet data are lacking in this area. Objective To estimate the prevalence of pulmonary arterial hypertension (PAH) following defect correction in patients with congenital heart disease (CHD). Data sources A systematic review and meta-analysis was performed using PubMed, Embase and Cochrane databases. Study selection Longitudinal cohort published between 1970-2023 involving CHD patients who underwent defect correction and were subsequently diagnosed with PAH were reviewed. Eligible studies reporting the prevalence of repaired PAH-CHD at least 3 months post-repair was included. Study selection was conducted independently by two reviewers. The primary outcome was the prevalence of PAH in patients following CHD defect correction. Results Across 58 studies (7,036 participants), the random-effects pooled prevalence of reported post-repair PAH/PH was 10.8% (95% CI 7.3-15.0, I2 = 95.6%; prediction interval 0-50.1%). Prevalence was 9.0% (95% CI 3.3-17) in studies using right heart catheterisation, 19.3% (CI 10.6-29.7) in studies using echocardiography and 16.1% (CI 8.6- 25.1%) in studies using both modalities (p=0.19). Prevalence was highest in the adult-only cohort (18.5%, 95%CI 11.8-26.2) and lower in paediatric only (7.6%, 95%CI 3-13.5) and mixed-age cohorts (7.5%,95%CI1.7-16.3), p=0.039. Preoperative pulmonary hypertension (PH) was the strongest predictor of post-repair PAH and remained predictive on adjusted meta-regression (p<0.01). Conclusion and relevance PAH following defect repair remains a significant clinical dilemma requiring standardised diagnostic criteria and robust risk stratification tools to guide management.

European Heart Journal - Quality of Care and Clinical Outcomes
Queen Elizabeth Hospital Birmingham (GB), Great Ormond Street Hospital (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Royal Hallamshire Hospital (GB), Freeman Hospital (GB), Royal Brompton Hospital (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), University College London (GB), Imperial College London (GB)
Good health and well-being
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon